A previous study found that APP/PS1 transgenic mice increased Aβ production and plaque formation at around 3–5 months of age [43]; developed mild impairments of spatial memory and nesting skill at 4.5 months of age [44]; and displayed cognitive deficits in the MWM [45]. Here, APP is linked to Cognitive impairment.